Prevalent Morphometrically Assessed Vertebral Fractures in Individuals With Type 2 Diabetes, Prediabetes and Normal Glucose Metabolism: The Maastricht Study

Autor: Veerle van Hulten, Cindy Sarodnik, Johanna H. M. Driessen, Nicolaas C. Schaper, Piet P. M. M. Geusens, Carol A. B. Webers, Geert-Jan Dinant, Ramon P. G. Ottenheijm, Nicklas H. Rasmussen, Rikke Viggers, Coen D. A. Stehouwer, Carla J. H. van der Kallen, Miranda T. Schram, Sandrine P. G. Bours, Pieter C. Dagnelie, Joop P. van den Bergh

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundType 2 diabetes (T2D) is frequently reported to be associated with an increased fracture risk. Epidemiological data on prevalent morphometric vertebral fractures (VFs) in T2D are sparse and even less is known in the prediabetic state.Purpos

Externí odkaz: https://doaj.org/article/4c56f9dc04d1474bb9af9ea5836f5690

The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

Autor: Zohreh Safipour, Joop P. W. van den Bergh, Frank de Vries, Peter Vestergaard, Paddy K.C. Janssen, Johanna H M Driessen, Rogier van der Zanden

Publikováno v: Osteoporosis International, 33(3), 649-658. Springer-Verlag London Ltd.
Safipour, Z, van der Zanden, R, van den Bergh, J, Janssen, P, Vestergaard, P, de Vries, F & Driessen, J H M 2022, ' The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis ', Osteoporosis International, vol. 33, no. 3, pp. 649–658 . https://doi.org/10.1007/s00198-021-06101-3

Summary: Oral glucocorticoids may increase major osteoporotic fracture risk (MOF) in myasthenia gravis patients. To assess this risk, we performed a case–control study including all Danish patients with a MOF between 1995 and 2011. We also pooled o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dccdee616548c07c333cc25392d28720
https://doi.org/10.1007/s00198-021-06101-3

Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer

Autor: Morten Hasselstrøm Jensen, Johannes T H Nielen, Olaf H. Klungel, Peter Vestergaard, Nikki C C Werkman, Johanna H M Driessen, Johan Røikjer, Joop P. W. van den Bergh, Frank de Vries, Nicolaas C. Schaper, Niels Ejskjaer

Publikováno v: Røikjer, J, Werkman, N C C, Ejskjær, N, van den Bergh, J P W, Vestergaard, P, Schaper, N C, Jensen, M H, Klungel, O H, de Vries, F, Nielen, J T H & Driessen, J H M 2022, ' Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer ', Diabetic Medicine, vol. 39, no. 4, e14725 . https://doi.org/10.1111/dme.14725
Diabetic Medicine, 39(4):e14725. Wiley

AIMS: A diabetic foot ulcer (DFU) is a severe condition associated with morbidity and mortality. Population-based studies are rare and limited by access to reliable data. Without this data, efforts in primary prevention cannot be evaluated. Therefore

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7966e0b69040b5d3d648e69fdf8c23
https://vbn.aau.dk/da/publications/168fa54d-eb9d-4ed8-a071-4194c0552eb2

The risk of new fragility fractures in patients with chronic kidney disease and hip fracture—a population-based cohort study in the UK

Autor: T P van Staa, I. J. A. de Bruin, Patrick C. Souverein, J. van den Bergh, Caroline E. Wyers, F. de Vries, Johanna H M Driessen, Piet Geusens

Publikováno v: de Bruin, I J A, Wyers, C E, Souverein, P C, van Staa, T P, Geusens, P P M M, van den Bergh, J P W, de Vries, F & Driessen, J H M 2020, ' The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK ', Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . https://doi.org/10.1007/s00198-020-05351-x
Osteoporosis International, 31(8), 1487-1497. Springer-Verlag London Ltd.
Osteoporosis International
Osteoporosis International, 31(8), 1487. Springer London

Summary Chronic kidney disease (CKD) is a risk factor for fractures. However, in hip fracture patients, CKD G3-G5 was associated with a higher mortality risk and not associated with a higher risk of subsequent non-hip fractures compared to eGFR > 60

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57f5eb9d31f09775b87e210bf58adf1
https://doi.org/10.1007/s00198-020-05351-x

Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study

Autor: Andrea M. Burden, Martijn C. G. J. Brouwers, Olaf H. Klungel, Frank de Vries, Judith van Dalem, Coen D.A. Stehouwer, Johanna H M Driessen

Publikováno v: Hepatology, 74(5), 2467-2477. Wiley
Hepatology, 74(5), 2467. John Wiley and Sons Ltd
Hepatobiliary Surg Nutr
Hepatology, 74 (5)

Background and Aims Thiazolidinediones (TZDs) and glucagon-like peptide-1 (GLP-1) receptor agonists are potential pharmacological treatment options for patients at risk of NAFLD. Therefore, we examined the association between the risk of NAFLD and th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bfc40d747e5917fda8b3d56bd86c6d8
https://cris.maastrichtuniversity.nl/en/publications/14fc2c6f-c54f-44bc-b40b-78abcff94ebc